Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Share of U.S. brand drugs meeting patent challenge before generic entry 1995-2014

Percentage of brand drug products that have experienced a drug patent challenge before generic entry from 1995 to 2014

by Matej Mikulic, last edited Jul 22, 2019
Share of U.S. brand drugs meeting patent challenge before generic entry 1995-2014 This statistic shows the percentage of branded drugs that have met a paragraph IV patent challenge prior to generic entry in the U.S. from 1995 to 2014. The percentage of drugs that have met patent challenges prior to generic entry has increased from 25 percent in 1995 to 94 percent in 2014.
Show more

Percentage of brand drug products that have experienced a drug patent challenge before generic entry from 1995 to 2014

Year of First Generic EntryPercentage of brand drugs
--
--
--
Year of First Generic EntryPercentage of brand drugs
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Download Settings Share
Download started
Please be patient - this may take a moment
by Matej Mikulic, last edited Jul 22, 2019
This statistic shows the percentage of branded drugs that have met a paragraph IV patent challenge prior to generic entry in the U.S. from 1995 to 2014. The percentage of drugs that have met patent challenges prior to generic entry has increased from 25 percent in 1995 to 94 percent in 2014.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Generics and biosimilars"
  • Global overview
The most important statistics
  • Top companies
  • U.S. market
  • Patent expiration
  • Savings
  • Biosimilars
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.